{"entity":{"id":"nicolas-penel","kind":"person","name":"Nicolas Penel","aka":[],"tldr":"Medical oncologist and sarcoma specialist who directs Institut Bergonié, the regional cancer centre for Nouvelle-Aquitaine in Bordeaux.","summary":"Nicolas Penel is Directeur Général of Institut Bergonié, the regional comprehensive cancer centre (Centre de Lutte Contre le Cancer) for Nouvelle-Aquitaine, based in Bordeaux with around 1,000 staff, more than 100 physicians and 159 beds serving nearly six million inhabitants. He is a medical oncologist and university professor at the University of Lille whose expertise is in sarcoma management and early-phase clinical trials, and he has authored or co-authored more than 450 indexed publications. Before joining Bergonié he spent ten years as Director of Clinical Research and Innovation at Centre Oscar Lambret in Lille. He was appointed to lead the institute's new strategic establishment project, working with deputy director general Céline Etchetto and research director Pierre Soubeyran.","asOf":"2026-09-10","links":[{"label":"Source: Institut Bergonié institutional page naming the direction","url":"https://www.bergonie.fr/linstitut/"}],"tags":["leadership","clinician-scientist","sarcoma","clinical-trials"],"related":[],"cancers":["sarcoma"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["institut-bergonie"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":["current-opinion-in-oncology"],"dependsOn":[],"notes":[],"role":"Directeur Général (Director General) of Institut Bergonié","institutionId":"institut-bergonie","specialisms":["Medical oncology","Sarcoma","Early-phase clinical trials"],"profiles":[{"label":"Institut Bergonié presentation page","url":"https://www.bergonie.fr/linstitut/"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Penel+N%5BAuthor%5D"}],"papers":[{"title":"Paclitaxel Given Once Per Week With or Without Bevacizumab in Patients With Advanced Angiosarcoma: A Randomized Phase II Trial","journal":"Journal of Clinical Oncology","year":2015,"doi":"10.1200/jco.2015.60.8505"},{"title":"Adult desmoid tumors: biology, management and ongoing trials","journal":"Current Opinion in Oncology","year":2017,"doi":"10.1097/cco.0000000000000374"},{"title":"Surgical versus non-surgical approach in primary desmoid-type fibromatosis patients: A nationwide prospective cohort from the French Sarcoma Group","journal":"European Journal of Cancer","year":2017,"doi":"10.1016/j.ejca.2017.06.017"}],"orcid":"0000-0001-5243-1548"},"route":"/people/nicolas-penel/","neighbours":{"cancer":[{"id":"sarcoma","kind":"cancer","name":"Sarcomas (soft tissue, bone, GIST)","route":"/cancers/sarcoma/"}],"institution":[{"id":"institut-bergonie","kind":"institution","name":"Institut Bergonié","route":"/institutions/institut-bergonie/"}],"journal":[{"id":"current-opinion-in-oncology","kind":"journal","name":"Current opinion in oncology","route":"/journals/current-opinion-in-oncology/"}]}}